Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate versus propofol for gastroscopy sedation and postoperative cognitive function
ChiCTR2100042277Phase 4Recruiting
- Sponsor
- Jinan Fifth People's Hospital
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of remimazolam and propofol in None (2 arms), sponsored by Jinan Fifth People's Hospital. Primary endpoint: Neurobehavioral Cognitive Status Examination. Started Feb 2021; status: recruiting.
02
Drugs
remimazolampropofol
Beyond the preview
Go deeper on ChiCTR2100042277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042277.